Antoni Caimari

Dr. Antoni Caimari

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJudit Companys
Judit Companys
MGMaria Jose Gosalbes
Maria Jose Gosalbes
LPLaura Pla-Pagà
Laura Pla-Pagà
LCLorena Calderón-Pérez
Lorena Calderón-Pérez
ELElisabet Llauradó
Elisabet Llauradó
RSRosa Solà
Rosa Solà
We aimed to differentiate gut microbiota composition of overweight/obese and lean subjects and to determine its association with clinical variables and dietary intake. A cross-sectional study was performed with 96 overweight/obese subjects and 32 lean subjects. Anthropometric parameters were positively associated with Collinsella aerofaciens, Dorea formicigenerans and Dorea longicatena, which had higher abundance the overweight/obese subjects. Moreover, different genera of Lachnospiraceae were negatively associated with body fat, LDL and total cholesterol. Saturated fatty acids (SFAs) were negatively associated with the genus Intestinimonas, a biomarker of the overweight/obese group, whereas SFAs were positively associated with Roseburia, a biomarker for the lean group. In conclusion, Dorea formicigenerans, Dorea longicatena and Collinsella aerofaciens could be considered obesity biomarkers, Lachnospiraceae is associated with lipid cardiovascular risk factors. SFAs exhibited opposite association profiles with butyrate-producing bacteria depending on the BMI. Thus, the relationship between diet and microbiota opens new tools for the management of obesity.

20 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
AMAnna Mas-Capdevila
Anna Mas-Capdevila
JTJoan Teichenné
Joan Teichenné
CDCristina Domenech-Coca
Cristina Domenech-Coca
ACAntoni Caimari
Antoni Caimari
JDJosep Maria DelBas
Josep Maria DelBas
ACAnna Crescenti
Anna Crescenti
Recently, hesperidin, a flavonone mainly present in citrus fruits, has emerged as a new potential therapeutic agent able to modulate several cardiovascular diseases (CVDs) risk factors. Animal and in vitro studies demonstrate beneficial effects of hesperidin and its derived compounds on CVD risk factors. Thus, hesperidin has shown glucose-lowering and anti-inflammatory properties in diabetic models, dyslipidemia-, atherosclerosis-, and obesity-preventing effects in CVDs and obese models, and antihypertensive and antioxidant effects in hypertensive models. However, there is still controversy about whether hesperidin could contribute to ameliorate glucose homeostasis, lipid profile, adiposity, and blood pressure in humans, as evidenced by several clinical trials reporting no effects of treatments with this flavanone or with orange juice on these cardiovascular parameters. In this review, we focus on hesperidin’s beneficial effects on CVD risk factors, paying special attention to the high interindividual variability in response to hesperidin-based acute and chronic interventions, which can be partly attributed to differences in gut microbiota. Based on the current evidence, we suggest that some of hesperidin’s contradictory effects in human trials are partly due to the interindividual hesperidin variability in its bioavailability, which in turn is highly dependent on the α-rhamnosidase activity and gut microbiota composition.

27 September 2018 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
RARosa Solà Alberich
Rosa Solà Alberich
RVRosa M Valls
Rosa M Valls
LCLorena Calderón-Pérez
Lorena Calderón-Pérez
ELElisabet Llauradó
Elisabet Llauradó
JCJudit Companys
Judit Companys
RSRosa Solà
Rosa Solà
Background The effects of probiotic Bifidobacterium animalis subsp. lactis CECT 8145 (Ba8145) and those of its heat-killed form (h-k Ba8145) on human anthropometric adiposity biomarkers are unknown. Objective To assess the effect of Ba8145 and h-k Ba8145 ingestion on anthropometric adiposity biomarkers. Design Randomized, parallel, double-blind, placebo-controlled trial with abdominally obese individuals. Participants (n = 135) consumed 1 capsule/day containing 1010 colony forming unit (CFU) of Ba8145, 1010 CFU of h-k Ba8145, or placebo (maltodextrin) for 3 months. Results Ba8145 ingestion decreased waist circumference, waist circumference/height ratio, and Conicity index (P < 0.05) versus its baseline. Changes versus the placebo group reached significance (P < 0.05) after the h-k Ba8145 treatment. Ba8145 decreased the body mass index compared with baseline and placebo group (P < 0.05). The decrease in visceral fat area after Ba8145 treatments reached significance (P < 0.05) only after h-k Ba8145. When analyses by gender were performed, significance remained only for women. Diastolic blood pressure and HOMA index decreased (P < 0.05) after h-k Ba8145. Gut microbiome analyses showed an increase in Akkermansia spp. after Ba8145 treatment, particularly in the live form, which was inversely related to weight (P = 0.003). Conclusions In abdominally obese individuals, consumption of Ba8145, both as viable and mainly as heat-killed cells, improves anthropometric adiposity biomarkers, particularly in women. An increase in the gut Akkermansia genus appears as a possible mechanism involved. Our results support Ba8145 probiotic as a complementary strategy in obesity management.

13 March 2007 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
Catalina PicóCatalina Picó
Catalina Picó
Paula OliverPaula Oliver
Paula Oliver
Juana SánchezJuana Sánchez
Juana Sánchez
OMO Miralles
O Miralles
ACAntoni Caimari
Antoni Caimari
Andreu PalouAndreu Palou
Andreu Palou

15 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJaume F. Lalanza
Jaume F. Lalanza
ACAntoni Caimari
Antoni Caimari
JDJosep Maria DelBas
Josep Maria DelBas
DTDaniel Torregrosa
Daniel Torregrosa
ICIgor Cigarroa
Igor Cigarroa
RERosa M Escorihuela
Rosa M Escorihuela
Among adolescents, overweight, obesity and metabolic syndrome are rapidly increasing in recent years as a consequence of unhealthy palatable diets. Animal models of diet-induced obesity have been developed, but little is known about the behavioural patterns produced by the consumption of such diets. The aim of the present study was to determine the behavioural and biochemical effects of a cafeteria diet fed to juvenile male and female rats, as well as to evaluate the possible recovery from these effects by administering standard feeding during the last week of the study. Two groups of male and female rats were fed with either a standard chow diet (ST) or a cafeteria (CAF) diet from weaning and for 8 weeks. A third group of males (CAF withdrawal) was fed with the CAF diet for 7 weeks and the ST in the 8th week. Both males and females developed metabolic syndrome as a consequence of the CAF feeding, showing overweight, higher adiposity and liver weight, increased plasma levels of glucose, insulin and triglycerides, as well as insulin resistance, in comparison with their respective controls. The CAF diet reduced motor activity in all behavioural tests, enhanced exploration, reduced anxiety-like behaviour and increased social interaction; this last effect was more pronounced in females than in males. When compared to animals only fed with a CAF diet, CAF withdrawal increased anxiety in the open field, slightly decreased body weight, and completely recovered the liver weight, insulin sensitivity and the standard levels of glucose, insulin and triglycerides in plasma. In conclusion, a CAF diet fed to young animals for 8 weeks induced obesity and metabolic syndrome, and produced robust behavioural changes in young adult rats, whereas CAF withdrawal in the last week modestly increased anxiety, reversed the metabolic alterations and partially reduced overweight.

15 May 2012 in International Journal of Obesity
Verified
Journal Article
Closed access
ACAntoni Caimari
Antoni Caimari
JDJosep Maria DelBas
Josep Maria DelBas
ACAnna Crescenti
Anna Crescenti
Lluís ArolaLluís Arola
Lluís Arola